LRRK2 and Parkinson disease: In conclusion, most LRRK2 rodents will not develop a PD-like synucleinopathy during their life but present with behavioral signs and functional changes that are reminiscent of prodromal PD, suggesting they can model the early cellular pathogenic events set in motion by the LRRK2 mutation.